Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

HealthIntell Articles

  • Causes of Acute intermittent porphyria

    Acute intermittent porphyria is caused by an inherited defect in one of the enzymes needed to make heme, the iron-containing molecule that helps hemoglobin, cytochromes, and other proteins function. In most cases, the underlying…

    Read article

  • Symptoms of Acute intermittent porphyria

    What are the symptoms of Acute intermittent porphyria? The condition most often produces severe abdominal pain, nausea, vomiting, constipation, dark urine, rapid heart rate, high blood pressure, anxiety, insomnia, and a range of nerve-related…

    Read article

  • What is Acute intermittent porphyria

    Acute intermittent porphyria is a rare inherited disorder of heme biosynthesis, the chemical pathway cells use to make heme, an iron-containing component needed for hemoglobin, myoglobin, and several metabolic enzymes. The condition primarily involves…

    Read article

  • FAQ about Mast cell activation syndrome

    Mast cell activation syndrome, often called MCAS, is a condition in which mast cells release chemical mediators too easily or too often. This FAQ explains what MCAS is, why it happens, how it is…

    Read article

  • Prevention of Mast cell activation syndrome

    Mast cell activation syndrome, often abbreviated as MCAS, is not a condition with a single known cause or a straightforward prevention pathway. In many people, it appears to develop from a combination of genetic…

    Read article

  • Diagnosis of Mast cell activation syndrome

    Mast cell activation syndrome, often abbreviated as MCAS, is diagnosed by combining clinical observation, laboratory evidence, and exclusion of other explanations. The condition involves inappropriate or excessive activation of mast cells, which are immune…

    Read article

  • Treatment for Mast cell activation syndrome

    What treatments are used for Mast cell activation syndrome? Management usually combines mast cell stabilizing medications, drugs that block the effects of released mediators, treatment of coexisting conditions, and long-term strategies that reduce the…

    Read article